ginkgolide b has been researched along with sirolimus in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
de Abreu Castro, MS; Dias, MF; Farinelli, P; Ferreira-Alves, DL; Francischi, JN; Kiyomi Funayama Tatsuo, MA; Pacheco, CM; Rocha, OA; Sirois, P | 1 |
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
2 other study(ies) available for ginkgolide b and sirolimus
Article | Year |
---|---|
Pharmacological characterization of Sephadex-induced oedema in rat paws: predominant role of serotonin and platelet-activating factor.
Topics: Animals; Bradykinin; Cyclosporine; Dexamethasone; Dextrans; Diterpenes; Edema; Ginkgolides; Histamine; Immunosuppressive Agents; Inflammation Mediators; Injections, Intravenous; Lactones; Male; Methysergide; p-Methoxy-N-methylphenethylamine; Platelet Activating Factor; Polyenes; Rats; Serotonin; Serotonin Antagonists; Sirolimus | 1996 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |